arginyl-glycyl-aspartic acid has been researched along with Diabetic Feet in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, RJ; McGill, JB; Prendergast, JJ; Ricotta, JJ; Schwartz, SL; Steed, DL; Webster, MW | 1 |
1 trial(s) available for arginyl-glycyl-aspartic acid and Diabetic Feet
| Article | Year |
|---|---|
Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Chronic Disease; Data Interpretation, Statistical; Diabetic Foot; Double-Blind Method; Female; Humans; Male; Middle Aged; Oligopeptides; Wound Healing | 1995 |